Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer

Bibliographic Details
Main Authors:	Li Zhang, Jun Zhou, Song Fan, Chao-Zhao Liang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Asian Journal of Andrology
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=654;epage=656;aulast=Zhang

Similar Items

The concentration of androgens and estrogens in benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2021-02-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
by: Yu Tong, et al.
Published: (2020-01-01)

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia
by: Lingmin Song, et al.
Published: (2016-07-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer.
by: Ana Caroline Hillebrand, et al.
Published: (2018-01-01)

Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
by: Ladan Dastgheib, et al.
Published: (2015-01-01)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
by: Sung-hee Oh, et al.
Published: (2020-06-01)

EPIDEMIOLOGY OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P I Chumakov, et al.
Published: (2018-12-01)

Benign Prostatic Hyperplasia
Published: (2015-01-01)

Benign prostatic hyperplasia
by: Ricardo L. V. Nunes, et al.

Correlation between Cholinergic Innervation, Autophagy, and Etiopathology of Benign Prostatic Hyperplasia
by: Jian-Liang Cai, et al.
Published: (2017-01-01)

Benign Prostatic Hyperplasia Treated Entirely by Unilateral Prostate Artery Embolization
by: Mohamed Shaker, et al.
Published: (2020-01-01)

The Effects of 8-Week Endurance Training on Prostatic Autophagy and Benign Prostatic Hyperplasia of Rats
by: Dong-Won Lee, et al.
Published: (2019-08-01)

Androgen deficiency and lower urinary tract symptoms in patients with benign prostatic hyperplasia
by: S. P. Darenkov, et al.
Published: (2014-11-01)

Combination Medical Therapy ( -Blockade and Androgen Suppression) in the Treatment of Benign Prostatic Hyperplasia
by: Safwan A. Taha, et al.
Published: (2002-12-01)

Androgen deficiency and lower urinary tract symptoms in patients with benign prostatic hyperplasia
by: S. P. Darenkov, et al.
Published: (2014-11-01)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia.
by: Fazarina M, et al.
Published: (2013)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Huge Benign Prostatic Hyperplasia
by: Seyed Yousef Hosseini, et al.
Published: (2004-06-01)

Treatment of benign prostatic hyperplasia
by: Ricardo Vita Nunes, et al.

Testosterone and benign prostatic hyperplasia
by: Thomas R Jarvis, et al.
Published: (2015-04-01)

Nocturia and benign prostatic hyperplasia
by: Laketić Darko, et al.
Published: (2008-01-01)

Androgen receptor CAG polymorphism and the risk of benign prostatic hyperplasia in a Brazilian population
by: Vanderlei Biolchi, et al.
Published: (2012-06-01)

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia
by: Minggen Yang, et al.
Published: (2021-09-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Ivan Pezelj, et al.
Published: (2018-01-01)

An Update on the Outcomes of Patients Treated with Urolift for Benign Prostatic Hyperplasia
by: Loloi J, et al.
Published: (2021-06-01)

Risk of Prostate Cancer in Men with Benign Prostatic Hyperplasia
by: Shih-Chang Hung, et al.
Published: (2014)

Prostatitis and Benign Prostatic Hyperplasia: Emerging Infectious Diseases?
by: Brad Hennenfent
Published: (1997-03-01)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
by: Somsri Wiwanitkit, et al.
Published: (2012-01-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

Is Effective in the Treatment of Benign Prostatic Hyperplasia?
by: Gökhan Çeker MD
Published: (2020-06-01)

extract in the treatment of benign prostatic hyperplasia
by: Petrisor Geavlete, et al.
Published: (2011-08-01)

Optimizing the management of benign prostatic hyperplasia
by: Dean S. Elterman, et al.
Published: (2012-04-01)

Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010-10-01)

Epidemiology of clinical benign prostatic hyperplasia
by: Kok Bin Lim
Published: (2017-07-01)

Doxazocin in management of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Solving the benign prostatic hyperplasia puzzle
by: Keong Tatt Foo
Published: (2016-01-01)

Pathophysiology of clinical benign prostatic hyperplasia
by: Keong Tatt Foo
Published: (2017-07-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)